Stockreport

Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield [Yahoo! Finance]

Tempus AI, Inc. - Class A  (TEM) 
PDF ALISO VIEJO, Calif., February 02, 2026 BUSINESS WIRE )--Ambry Genetics, a leader in clinical genomic testing, and now a wholly owned subsidiary of Tempus AI, Inc. (NASD [Read more]